AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMRICOR MEDICAL SYSTEMS-CDI

1.975

+0.0653.40%

Volume:162.20K

Turnover:322.58K

Market Cap:633.87M

PE:-9.97

High:2.050

Open:1.965

Low:1.945

Close:1.910

52wk High:2.250

52wk Low:1.115

Shares:320.95M

Float Shares:275.05M

Volume Ratio:1.83

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.198

EPS(LYR):-0.133

ROE:-432.29%

ROA:-38.22%

PB:19.42

PE(LYR):-14.90

Loading ...

Overview Company News Filings

BRIEF-Imricor Medical Systems Submits Advantage-MR System For FDA 510(K) Clearance

Imricor Medical Systems Submits Product for US FDA Clearance

MT Newswires Live

Imricor Medical Systems Inc - Imricor Submits Advantage-Mr System for FDA 510(K) Clearance

THOMSON REUTERS

Imricor Medical Systems Names Specialty Hospital as Fourth US Site for Heart Procedure Trial

MT Newswires Live

BRIEF-Imricor Medical Systems Recieves FDA Clearance For Northstar

Imricor Secures US FDA Clearance for NorthStar Mapping System; Shares Hit Five-Year High

MT Newswires Live

Imricor Medical Systems Inc - Imricor Recieves FDA Clearance for Northstar®

THOMSON REUTERS

Imricor Says Near-Term Commercial Goal to Execute, Convert Existing Opportunities Rather Than Pipeline Expansion

MT Newswires Live

Imricor Medical Systems Names US Academic Health System as Third Site for Heart Procedure Trial

MT Newswires Live

Imricor Medical Systems Insiders Benefitted From Selling Stock At US$1.68

Simply Wall St.

BRIEF-Imricor Medical Systems Says FDA Clears Vision-Mr Diagnostic Catheter

BUZZ-Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter

Imricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High

MT Newswires Live

Imricor Names German University Hospital as Second Site for Heart Procedure Trial; Shares Rise 4%

MT Newswires Live

BRIEF-Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical Trial

Imricor Enrolls US University's Academic Health System as Site for Atrial Flutter Treatment Trial

MT Newswires Live

Imricor Medical Systems - Institutional Review Board Approved Uva Health's Enrolment in Co's Visabl-Afl Clinical Trial

THOMSON REUTERS

Is Imricor Medical Systems (ASX:IMR) Using Debt In A Risky Way?

Simply Wall St.

Imricor Medical Systems Inc-Imricor Appoints Aldo Denti to Board of Directors

THOMSON REUTERS

ASX Midday Sector Update: Healthcare Stocks Stay in Green, Utilities Sector Leads Selloff

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMR.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.975,"timestamp":1770700320000,"preClose":1.91,"halted":0,"volume":162201,"delay":0,"changeRate":0.034031413612565536,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":320947028,"eps":-0.198135,"marketStatus":"Not Yet Opened","change":0.065,"latestTime":"02-10 16:12:00 AEDT","open":1.965,"high":2.05,"low":1.945,"amount":322576,"amplitude":0.054974,"askPrice":1.98,"askSize":10000,"bidPrice":1.95,"bidSize":1536,"shortable":3,"etf":0,"ttmEps":-0.198135,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":1.91,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":1.825511,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-38.22%","roe":"-432.29%","lyrEps":-0.132557,"volumeRatio":1.825511,"shares":320947028,"dividePrice":0,"high":2.05,"amplitude":0.054974,"preClose":1.91,"low":1.945,"week52Low":1.115,"pbRate":"19.42","psRate":"598.72","week52High":2.25,"institutionHeld":0,"latestPrice":1.975,"committee":-0.733703,"eps":-0.198135,"divideRate":0,"volume":162201,"delay":0,"ttmEps":-0.198135,"open":1.965,"prevYearClose":1.53,"prevWeekClose":1.87,"prevMonthClose":1.98,"prevQuarterClose":1.53,"fiveDayClose":2.03,"twentyDayClose":1.85,"sixtyDayClose":1.455,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null},{"date":"2024-02-29","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609653998","title":"BRIEF-Imricor Medical Systems Submits Advantage-MR System For FDA 510(K) Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2609653998","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609653998?lang=en_us&edition=fundamental","pubTime":"2026-02-06 09:04","pubTimestamp":1770339876,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Submits Advantage-MR System For FDA 510(K) ClearanceFeb 6 (Reuters) - Imricor Medical Systems Inc IMR.AX:IMRICOR SUBMITS ADVANTAGE-MR SYSTEM FOR FDA 510(K) CLEARANCEFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z11LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","IMR.AU","BK7508","BK7007"],"gpt_icon":0},{"id":"2609353340","title":"Imricor Medical Systems Submits Product for US FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2609353340","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609353340?lang=en_us&edition=fundamental","pubTime":"2026-02-06 07:01","pubTimestamp":1770332518,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) submitted its Advantage-MR EP Recorder/Stimulator system for US Food and Drug Administration market clearance, according to a Friday filing with the Australian bourse","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7503","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2609587180","title":"Imricor Medical Systems Inc - Imricor Submits Advantage-Mr System for FDA 510(K) Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2609587180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609587180?lang=en_us&edition=fundamental","pubTime":"2026-02-06 05:54","pubTimestamp":1770328472,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nFWN3Z11LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7503","IMR.AU","BK7508","BK7007"],"gpt_icon":0},{"id":"2608155788","title":"Imricor Medical Systems Names Specialty Hospital as Fourth US Site for Heart Procedure Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2608155788","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608155788?lang=en_us&edition=fundamental","pubTime":"2026-02-03 06:31","pubTimestamp":1770071490,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said the Oklahoma Heart Institute  will serve as the fourth US site for its Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter  clinical trial, according to a Tuesday filing with the Australian bourse.The trial is investigating the safety and efficacy of radio-frequency ablation of ventricular tachycardia performed with the company's product, Vision-MR Ablation Catheter 2.0, the company said in an August 2023 statement.The company expects to start procedures at OHI in March, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","OHI","BK7503","IMR.AU","BK4225","BK4203","BK7508","BK7007"],"gpt_icon":0},{"id":"2607720999","title":"BRIEF-Imricor Medical Systems Recieves FDA Clearance For Northstar","url":"https://stock-news.laohu8.com/highlight/detail?id=2607720999","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607720999?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:26","pubTimestamp":1769650016,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Recieves FDA Clearance For NorthstarJan 29 (Reuters) - Imricor Medical Systems IMR.AX:IMRICOR RECIEVES FDA CLEARANCE FOR NORTHSTAR®Further company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","BK7007","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2607724972","title":"Imricor Secures US FDA Clearance for NorthStar Mapping System; Shares Hit Five-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2607724972","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607724972?lang=en_us&edition=fundamental","pubTime":"2026-01-29 08:13","pubTimestamp":1769645613,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said that the US Food and Drug Administration  has cleared its NorthStar Mapping System, marking the company's second FDA clearance in January, following earlier approval of the VisionMR Diagnostic Catheter, according to a Thursday filing with the Australian bourse.The approval allows the company to market NorthStar in the US, establishing it as the core system of interventional cardiac magnetic resonance imaging  labs, with further approvals anticipated as the company expands its MRI-guided electrophysiology platform, the filing added.The company's shares rose 12% in recent Thursday trade, earlier hitting a five-year high.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","IMR.AU","BK7503","BK7508"],"gpt_icon":0},{"id":"2607172350","title":"Imricor Medical Systems Inc - Imricor Recieves FDA Clearance for Northstar®","url":"https://stock-news.laohu8.com/highlight/detail?id=2607172350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607172350?lang=en_us&edition=fundamental","pubTime":"2026-01-29 05:36","pubTimestamp":1769636204,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YT19B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IMR.AU","BK7007","BK7503"],"gpt_icon":0},{"id":"2606075075","title":"Imricor Says Near-Term Commercial Goal to Execute, Convert Existing Opportunities Rather Than Pipeline Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2606075075","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606075075?lang=en_us&edition=fundamental","pubTime":"2026-01-28 10:02","pubTimestamp":1769565772,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems (ASX:IMR) said that with its pipeline now exceeding 40 sites, its near-term commercial focus will be on executing and converting existing opportunities rather than further expanding its pipeline, according to a Wednesday filing with the Australian bourse.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7007","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2605883128","title":"Imricor Medical Systems Names US Academic Health System as Third Site for Heart Procedure Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2605883128","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605883128?lang=en_us&edition=fundamental","pubTime":"2026-01-21 08:12","pubTimestamp":1768954351,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said Virginia Commonwealth University Health in the US will serve as the third site in the company's Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter  clinical trial, according to a Wednesday filing with the Australian bourse.The trial investigates the safety and efficacy of radiofrequency ablation of ventricular tachycardia performed with the company's product Vision-MR Ablation Catheter 2.0, the company said in an August 2023 statement.The company expects to start final budgeting, installation, and training at the site in February and procedures in March, the filing said.Shares of the company fell 1% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","BK7508","IMR.AU","BK7007"],"gpt_icon":0},{"id":"2604901411","title":"Imricor Medical Systems Insiders Benefitted From Selling Stock At US$1.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2604901411","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604901411?lang=en_us&edition=fundamental","pubTime":"2026-01-19 06:02","pubTimestamp":1768773745,"startTime":"0","endTime":"0","summary":"While it’s been a great week for Imricor Medical Systems, Inc. ( ASX:IMR ) shareholders after stock gained 19%, company...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/imricor-medical-systems-insiders-benefitted-from-selling-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/imricor-medical-systems-insiders-benefitted-from-selling-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IMR.AU","BK7007","BK7503","BK7508"],"gpt_icon":0},{"id":"2602566739","title":"BRIEF-Imricor Medical Systems Says FDA Clears Vision-Mr Diagnostic Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2602566739","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602566739?lang=en_us&edition=fundamental","pubTime":"2026-01-12 08:51","pubTimestamp":1768179084,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says FDA Clears Vision-Mr Diagnostic CatheterJan 12 (Reuters) - Imricor Medical Systems Inc IMR.AX:FDA CLEARS VISION-MR DIAGNOSTIC CATHETERFurther company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YA1SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7007","BK7503","IMR.AU"],"gpt_icon":0},{"id":"2602565223","title":"BUZZ-Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2602565223","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602565223?lang=en_us&edition=fundamental","pubTime":"2026-01-12 08:05","pubTimestamp":1768176332,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Imricor Medical Systems soars on US FDA clearance for MRI catheter** Shares of Australia's Imricor Medical Systems IMR.AX rise as much as 26% to A$1.99, their highest level since July","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nL6N3YD000:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7503","BK7007","IMR.AU"],"gpt_icon":0},{"id":"2602565517","title":"Imricor Medical Systems Receives FDA Clearance; Shares Reach Four-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2602565517","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602565517?lang=en_us&edition=fundamental","pubTime":"2026-01-12 07:41","pubTimestamp":1768174881,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  received 510 clearance for its Vision-MR diagnostic catheter under the premarket notification process with the US Food and Drug Administration, according to a Monday filing with the Australian bourse.The clearance allows the company to commercially market the catheter, which is designed to be used under real-time magnetic resonance imaging guidance, in the US, the filing saidThe company expects to obtain multiple regulatory clearances and approvals this year, as per the filing.Shares rose more than 25% in morning trade on Monday and earlier reached their highest since July 2021.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7508","IMR.AU","BK7503"],"gpt_icon":0},{"id":"2592332401","title":"Imricor Names German University Hospital as Second Site for Heart Procedure Trial; Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592332401","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592332401?lang=en_us&edition=fundamental","pubTime":"2025-12-19 08:51","pubTimestamp":1766105477,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  said Charite University Hospital in Berlin will serve as the second site of its clinical trial evaluating real-time magnetic resonance imaging-guided ventricular ablation, according to a Friday filing with the Australian bourse.The so-called VISABL-VT trial launched in Amsterdam in April with the first-in-human ventricular ablation guided by real-time magnetic resonance imaging with the company's NorthStar mapping system, the company said in an April statement.The company also expects to start atrial flutter ablations at the site in the first quarter of 2026, the filing said.Shares of the company rose 4% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","BK7508","BK7007","IMR.AU"],"gpt_icon":0},{"id":"2591693383","title":"BRIEF-Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591693383","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591693383?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:04","pubTimestamp":1765760690,"startTime":"0","endTime":"0","summary":"BRIEF-Imricor Medical Systems Says IRB Approved UVA Health's Enrolment In Visabl-Afl Clinical TrialDec 15 (Reuters) - Imricor Medical Systems Inc IMR.AX:INSTITUTIONAL REVIEW BOARD APPROVED UVA HEALTH'","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XI0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7503","BK7508","IMR.AU"],"gpt_icon":0},{"id":"2591066032","title":"Imricor Enrolls US University's Academic Health System as Site for Atrial Flutter Treatment Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591066032","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591066032?lang=en_us&edition=fundamental","pubTime":"2025-12-15 07:34","pubTimestamp":1765755243,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems  enrolled UVA Health to serve as the second US site for the company's Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter  clinical trial, according to a Monday filing with the Australian bourse.The company expects the final approval of the site's research contract in the coming days, site installation and clinical training in January 2026, and to start procedures in February 2026, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMR.AU","BK7508","BK7007","BK7503"],"gpt_icon":0},{"id":"2591629976","title":"Imricor Medical Systems  -  Institutional Review Board Approved Uva Health's Enrolment in Co's Visabl-Afl Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2591629976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591629976?lang=en_us&edition=fundamental","pubTime":"2025-12-15 05:25","pubTimestamp":1765747543,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nFWN3XI0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","IMR.AU","BK7503","BK7508"],"gpt_icon":0},{"id":"2586299905","title":"Is Imricor Medical Systems (ASX:IMR) Using Debt In A Risky Way?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299905","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299905?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:20","pubTimestamp":1764199234,"startTime":"0","endTime":"0","summary":"Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/is-imricor-medical-systems-asximr-using-debt-in-a-risky-way","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-imr/imricor-medical-systems-shares/news/is-imricor-medical-systems-asximr-using-debt-in-a-risky-way","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","IMR.AU","BK7503","BK7508","EBIT"],"gpt_icon":0},{"id":"2582816521","title":"Imricor Medical Systems Inc-Imricor Appoints Aldo Denti to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2582816521","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582816521?lang=en_us&edition=fundamental","pubTime":"2025-11-10 05:54","pubTimestamp":1762725276,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251109:nTUEKLLKV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7007","BK7503","IMR.AU"],"gpt_icon":0},{"id":"2580279060","title":"ASX Midday Sector Update: Healthcare Stocks Stay in Green, Utilities Sector Leads Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2580279060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580279060?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:29","pubTimestamp":1762223380,"startTime":"0","endTime":"0","summary":"The healthcare sector inched up just 0.1% at midday Tuesday, with all other sectors on the Australian bourse trading in the red. The Reserve Bank of Australia is expected to maintain its monetary policy at its meeting today.Imricor Medical Systems , whose shares jumped over 11%, said the first in-human ischemic ventricular tachycardia ablation ever performed under real-time magnetic resonance imaging  guidance was completed in an interventional cardiac magnetic resonance imaging laboratory. The procedure was performed at the Amsterdam University Medical Centre.On the flip side, the utilities sector led the selloff, falling more than 2%.Energy World  appointed Joseph Meyer as chief financial officer, effective Nov. 1.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","BK7503","BK4581","BK4585","BK7032","HCSG","XAO.AU","XKO.AU","XJO.AU","BK4137","XLV","LU0029874061.USD","BK4588","EWC.AU","LABU","IMR.AU","BK7508","LU0128526141.USD","XBI"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}]}}